169 related articles for article (PubMed ID: 24508816)
1. Rapid screening of protein-protein interaction inhibitors using the protease exclusion assay.
Nirantar SR; Li X; Siau JW; Ghadessy FJ
Biosens Bioelectron; 2014 Jun; 56():250-7. PubMed ID: 24508816
[TBL] [Abstract][Full Text] [Related]
2. Molecular rotors as conditionally fluorescent labels for rapid detection of biomolecular interactions.
Goh WL; Lee MY; Joseph TL; Quah ST; Brown CJ; Verma C; Brenner S; Ghadessy FJ; Teo YN
J Am Chem Soc; 2014 Apr; 136(17):6159-62. PubMed ID: 24494589
[TBL] [Abstract][Full Text] [Related]
3. Phase-separated condensate-aided enrichment of biomolecular interactions for high-throughput drug screening in test tubes.
Zhou M; Li W; Li J; Xie L; Wu R; Wang L; Fu S; Su W; Hu J; Wang J; Li P
J Biol Chem; 2020 Aug; 295(33):11420-11434. PubMed ID: 32461254
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
[TBL] [Abstract][Full Text] [Related]
5. Case Study: discovery of inhibitors of the MDM2-p53 protein-protein interaction.
Liu L; Bernard D; Wang S
Methods Mol Biol; 2015; 1278():567-85. PubMed ID: 25859977
[TBL] [Abstract][Full Text] [Related]
6. A cell-based high-throughput assay for the screening of small-molecule inhibitors of p53-MDM2 interaction.
Li J; Zhang S; Gao L; Chen Y; Xie X
J Biomol Screen; 2011 Apr; 16(4):450-6. PubMed ID: 21471462
[TBL] [Abstract][Full Text] [Related]
7. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
Sirous H; Chemi G; Campiani G; Brogi S
Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
[TBL] [Abstract][Full Text] [Related]
8. A facile method to screen inhibitors of protein-protein interactions including MDM2-p53 displayed on T7 phage.
Ishi K; Sugawara F
Biochem Pharmacol; 2008 May; 75(9):1743-50. PubMed ID: 18384755
[TBL] [Abstract][Full Text] [Related]
9. Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.
Mo XL; Luo Y; Ivanov AA; Su R; Havel JJ; Li Z; Khuri FR; Du Y; Fu H
J Mol Cell Biol; 2016 Jun; 8(3):271-81. PubMed ID: 26578655
[TBL] [Abstract][Full Text] [Related]
10. A re-examination of the MDM2/p53 interaction leads to revised design criteria for novel inhibitors.
Vasilevich NI; Afanasyev II; Kovalskiy DA; Genis DV; Kochubey VS
Chem Biol Drug Des; 2014 Nov; 84(5):585-92. PubMed ID: 24797588
[TBL] [Abstract][Full Text] [Related]
11. Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53-MDM2 interaction with a distinct binding mode.
Gessier F; Kallen J; Jacoby E; Chène P; Stachyra-Valat T; Ruetz S; Jeay S; Holzer P; Masuya K; Furet P
Bioorg Med Chem Lett; 2015 Sep; 25(17):3621-5. PubMed ID: 26141769
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule MDM2-p53 inhibitors: recent advances.
Zhang B; Golding BT; Hardcastle IR
Future Med Chem; 2015; 7(5):631-45. PubMed ID: 25921402
[TBL] [Abstract][Full Text] [Related]
13. Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
Brandão P; Loureiro JB; Carvalho S; Hamadou MH; Cravo S; Moreira J; Pereira D; Palmeira A; Pinto M; Saraiva L; Cidade H
Eur J Med Chem; 2018 Aug; 156():711-721. PubMed ID: 30041135
[TBL] [Abstract][Full Text] [Related]
14. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors.
Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N
Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030
[TBL] [Abstract][Full Text] [Related]
15. Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.
Vaupel A; Bold G; De Pover A; Stachyra-Valat T; Lisztwan JH; Kallen J; Masuya K; Furet P
Bioorg Med Chem Lett; 2014 May; 24(9):2110-4. PubMed ID: 24704029
[TBL] [Abstract][Full Text] [Related]
16. Competition NMR for Detection of Hit/Lead Inhibitors of Protein-Protein Interactions.
Musielak B; Janczyk W; Rodriguez I; Plewka J; Sala D; Magiera-Mularz K; Holak T
Molecules; 2020 Jul; 25(13):. PubMed ID: 32630327
[TBL] [Abstract][Full Text] [Related]
17. A fluorescent-based high-throughput screening assay for small molecules that inhibit the interaction of MdmX with p53.
Tsuganezawa K; Nakagawa Y; Kato M; Taruya S; Takahashi F; Endoh M; Utata R; Mori M; Ogawa N; Honma T; Yokoyama S; Hashizume Y; Aoki M; Kasai T; Kigawa T; Kojima H; Okabe T; Nagano T; Tanaka A
J Biomol Screen; 2013 Feb; 18(2):191-8. PubMed ID: 22989451
[TBL] [Abstract][Full Text] [Related]
18. AlphaScreen-Based Assays: Ultra-High-Throughput Screening for Small-Molecule Inhibitors of Challenging Enzymes and Protein-Protein Interactions.
Yasgar A; Jadhav A; Simeonov A; Coussens NP
Methods Mol Biol; 2016; 1439():77-98. PubMed ID: 27316989
[TBL] [Abstract][Full Text] [Related]
19. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
[TBL] [Abstract][Full Text] [Related]
20. Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction.
Jacoby E; Boettcher A; Mayr LM; Brown N; Jenkins JL; Kallen J; Engeloch C; Schopfer U; Furet P; Masuya K; Lisztwan J
Methods Mol Biol; 2009; 575():173-94. PubMed ID: 19727615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
